T1D-Plus study with Dexcom
key details
| Status | complete |
|---|---|
| Procedure | direct |
| OCID | ocds-h6vhtk-060896 |
Awards (2)
This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| 91,200 shared | £76,000 | 19 Jan 2026 | active |
| Dexcom International Limited shared | £76,000 | 19 Jan 2026 | active |
description
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023.
An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Jan 2026 | Contract award (UK6) | Procurement Act 2023 | 004296-2026 |
| 19 Jan 2026 | Contract details (UK7) | Procurement Act 2023 | 004306-2026 |
more from CARDIFF UNIVERSITY
- Radiopharmaceuticals 18FDG · 24 Jul 2026
- Car Parking Management · 23 Jul 2026
- Residences Low Occupancy Water Flushing · £150,000 · 13 Jul 2026
- Flexible Lifelong Learning · £5,000,000 · 10 Jul 2026
- Turnitin 2026-29 · 7 Jul 2026
- Thermal Manikin · £118,000 · 29 Jun 2026
- Structured Cabling · £190,000 · 29 Jun 2026
- PSMA Radiopharmaceuticals · 26 Jun 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.